ipratropium bromide


Boehringer Ingelheim


Agencia Lei Va Hong
Concise Prescribing Info
Ipratropium Br anhydrous
MDI Bronchodilator for maintenance treatment of bronchospasm associated w/ COPD, including chronic bronchitis, emphysema & asthma. Inhalation soln Bronchodilator for the prevention & treatment of symptoms in chronic obstructive airway disorder w/ reversible bronchospasm eg, bronchial asthma & especially chronic bronchitis w/ or w/o emphysema.
Dosage/Direction for Use
MDI Adult & childn >6 yr 2 puffs qds. Max: 12 puffs. Inhalation soln Adult (including elderly) & adolescent >14 yr 0.4-2 mL. Childn 6-14 yr 0.4-1 mL, <6 yr 0.4-1 mL given under medical supervision. All doses to be diluted w/ saline up to 3-4 mL & inhaled tds-qds.
Hypersensitivity to atropine or its derivatives.
Special Precautions
Patients predisposed to narrow-angle glaucoma; cystic fibrosis. Pregnancy & lactation. MDI Micturition disorders (eg, prostatic hypertrophy or bladder-neck obstruction). May impair ability to drive or operate machinery. Ocular complication.
Adverse Reactions
GI motility disorders, dry mouth, headache, increased heart rate, palpitations, supraventricular tachycardia, atrial fibrillation, ocular accommodation disorder, nausea, urinary retention, dizziness, cough, throat irritation, bronchospasm, rash, hypersensitivity, anaphylactic reaction.
Drug Interactions
Bronchodilatory effect may be intensified by β-adrenergics & xanthine prep.
MIMS Class
Antiasthmatic & COPD Preparations
ATC Classification
R03BB01 - ipratropium bromide ; Belongs to the class of other inhalants used in the treatment of obstructive airway diseases, anticholinergics.
Atrovent MDI (CFC-free) 20 mcg/puff
(CFC-free) 200 puff x 1's
Atrovent inhalation soln 0.025%
20 mL x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in